Key result
Higher muscle mass linked to ~2.6-point lower physical fatigability score in African Caribbean men.
Why the study?
Are measures of muscle mass and quality associated with lower perceived physical fatigability in older African Caribbean men?
Cross-Sectional (n=205)
Are measures of muscle mass and quality associated with lower perceived physical fatigability in older African Caribbean men?
Effect estimate: 2.6 points lower PFS score per 1 SD increment
p-value: p=0.0425
Total body muscle mass assessed by D3 creatine dilution is associated with lower perceived physical fatigability in older African Caribbean men, suggesting muscle mass as a potential target to reduce fatigability and its cardiovascular sequelae.
Background: Fatigability, the degree of fatigue experienced in response to activities of standardized intensity and duration, is a well-recognized marker of functional decline, morbidity, and mortality, and is emerging as a potential risk factor for cardiovascular disease (CVD). In the disablement pathway, greater fatigability tends to follow lower muscle quantity and quality, known risk factors for CVD, highlighting a potential area for intervention. Older African ancestry individuals also have higher levels of muscle fat and a greater burden of cardio-metabolic disease than those of European ancestry. Therefore, we leveraged data from the Tobago Health Study with the aim of identifying which measures of muscle mass and quality were most closely associated cross-sectionally with lower perceived fatigability among 205 older African Caribbean men. Methods: Calf muscle area (MA), intermuscular fat (IMF), and muscle density (MD) were assessed via peripheral quantitative computed tomography. IMF and MD are measures of ectopic fat within muscle, and by extension, muscle quality. Appendicular lean mass (ALM) was assessed using dual-energy x-ray absorptiometry. In a subset of 45 men, total body muscle mass was assessed directly using the novel D 3 creatine dilution assay (D 3 CrMM). Perceived physical fatigability was assessed using the Pittsburgh Fatigability Scale – Caribbean Version (PFS; range 0–50; higher PFS score=greater fatigability). Associations of muscle values with PFS were tested using linear regression adjusted for age, height, weight, height-weight interaction, and device-measured daily step count. BMI was also included as a comparator. Results: Men on average were 68.0 ± 4.3 years old, generally overweight (BMI = 27.6 ± 5.1 kg/m 2 ), highly active (7001 ± 3940 steps/day), and had higher PFS Physical scores (20.0 ± 8.1). Each 1 SD increment higher D 3 CrMM (6.4kg) was associated with 2.6 points lower PFS score (p=.0425). MA, IMF, MD, and ALM were not associated with PFS Physical score. Conclusion: Higher levels of the novel D 3 creatine dilution measure of total body muscle mass were cross-sectionally associated with lower perceived physical fatigability in this sample of African Caribbean men. Further study is warranted with larger samples, but our study provides new evidence that increasing muscle mass could be a target for intervention in reducing the burden of physical fatigability and its sequelae.
No takes yet. Share an insight, caveat, or question.
CVEJKUS et al. (2026) conducted a cross-sectional in Perceived physical fatigability (n=205). Total body muscle mass assessed by D3 creatine dilution vs. Lower muscle mass was evaluated on Perceived physical fatigability assessed using the Pittsburgh Fatigability Scale (2.6 points lower PFS score per 1 SD increment, p=0.0425). Higher total body muscle mass assessed by D3 creatine dilution was associated with lower perceived physical fatigability (2.6 points lower per 1 SD increment, p=0.0425) in African Caribbean men.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: